Nutrient sensing — mTOR, AMPK & caloric restriction mimetics
One of 6 mechanistic pathways to ⏳ Longevity & healthspan · 13 options
The most conserved longevity mechanism across every species tested. Persistent nutrient abundance signals growth; scarcity signals repair and maintenance. Everything in this pathway is a way of telling the cell that food is scarce when it isn't.
Fasting insulin and IGF-1 are the two readable outputs of the nutrient-sensing system this whole pathway targets. They also tell you whether an intervention is doing anything, which nothing else here does.
Fasting InsulinHbA1c (Hemoglobin A1c)IGF-1 (Insulin-like Growth Factor 1)Uric AcidComprehensive Metabolic Panel (CMP)⏳ Longevity Baseline covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 Rapamycin
mTOR inhibition is the single most reproducible pharmacological lifespan extension in mammals — the NIA Interventions Testing Program replicated it repeatedly, including in mice started late in life. Human longevity data does not exist; the immunosuppression at transplant doses is why intermittent low-dose protocols are what people actually discuss.
💉 Metformin
AMPK activation and complex-I inhibition. The TAME trial was designed to test it as a geroprotector and has struggled for funding. Note the awkward finding that it blunts exercise adaptation, which matters if training is your other longevity intervention.
💉 Acarbose
Extended lifespan in the ITP, more strongly in male mice. Flattens glucose excursions and feeds colonic fermentation — two plausible mechanisms for one cheap approved drug.
💉 Canagliflozin
Also extended male mouse lifespan in the ITP. SGLT2 inhibition produces a mild caloric deficit plus ketone elevation.
💉 AICAR
Direct AMPK activation — the exercise-mimetic route into the same nutrient-sensing switch.
💉 MOTS-c
AMPK activation from a mitochondrially-encoded peptide. Levels decline with age, which is the argument for restoring them.
💉 17-alpha-Estradiol
Extended male mouse lifespan in the ITP without feminizing effects — it appears to work through hypothalamic inflammation and metabolic signaling rather than classical estrogen receptors. One of the strangest and most interesting ITP results.
💉 Klotho (alphaKlothoLR)
Alpha-Klotho is the endogenous version of this pathway's argument: it dampens insulin/IGF-1 and Wnt signaling — the same axis Rapamycin and Metformin are aimed at — and it falls with age and further in kidney disease. Mouse overexpression extends lifespan and one primate study improved cognition. There is no human administration data at all, which is a very long way from a mouse.
🧬 Berberine
AMPK activation with genuine human metabolic data. The accessible version of this pathway.
🧬 Dihydroberberine
The same argument with better absorption.
🧬 Calcium AKG
Extended lifespan and compressed morbidity in mice. AKG is a TCA intermediate and a cofactor for the dioxygenases that regulate DNA methylation — which is a mechanistically rich place to be.
🧬 Spermidine
Dietary spermidine intake correlates with lower all-cause mortality in prospective human cohorts. It induces autophagy, which is a mechanism that connects the epidemiology to something real.
🧬 Green Tea (EGCG)
EGCG has mTOR-inhibiting and AMPK-activating activity in vitro, and green tea consumption tracks with lower mortality in Japanese cohorts.
What actually decides this outcome, in order of size
Every headline on this page belongs to an animal of a stated species, sex and age, and the sex turns out to matter more than the mechanism. Ranked by how much of the outcome each one owns:
- The species and the sex of the result you are copying. Rapamycin fed late in life extended lifespan in genetically heterogeneous mice Harrison 2009. In the same program, 17-alpha-estradiol extended lifespan in male mice and nicotinamide riboside and three other compounds did not extend it in either sex Harrison 2021. Canagliflozin's geroprotective signal has been reported with an explicit sex dependence Snyder 2023 Wezeman 2022. A reader taking one of these has assumed a translation nobody has demonstrated.
- Whether there is a human endpoint anywhere on the page, and for one item there is. Metformin and lifestyle were examined against diabetes incidence over 21 years Knowler 2025 and against mortality in the same program Lee 2021. That is the only human outcome file on this list, and its finding was heterogeneity rather than a uniform benefit.
- Schedule, because for the best-evidenced molecule here the schedule is the safety strategy. Alternative rapamycin regimens have been examined for their effect on the drug's costs Arriola Apelo 2016, and intermittent feeding recapitulates some effects of continuous exposure Baghdadi 2024. Continuous mTOR inhibition is an immunosuppressive dose; intermittent is a different exposure with different consequences and no human longevity data either way.
- Whether the reader is already doing the thing the drug mimics. These are nutrient-scarcity signals. Somebody who trains, eats moderately and is metabolically healthy already spends a large part of the week with AMPK engaged and mTOR quiet, which is the baseline in which a mimetic has the least room to work.
- The rest of the list, and its evidence is human epidemiology or invertebrate biology. Alpha-ketoglutarate extended lifespan by inhibiting ATP synthase in a model organism Chin 2014; spermidine produced cardioprotection and lifespan extension in animals Eisenberg 2016 and higher dietary intake tracks lower mortality in a prospective human cohort Kiechl 2018, which is an association rather than a trial.
The order to run these in, and what has to be true first
Take the one intervention with human outcome data seriously first, treat the rest as experiments, and never run two mTOR-adjacent agents at once. The reason for the last rule is that they share a read-out and you will not know which one moved it.
- The behavioral version of every mechanism on this page is free and already available. Fasting periods, endurance work and resistance training engage AMPK and modulate mTOR without a prescription, and the 21-year lifestyle arm is the closest thing to a human longevity trial anybody has Knowler 2025. That is not a reason to avoid the pharmacology; it is the comparator it has to beat.
- Baseline panel before anything, because most of these move it. HbA1c (Hemoglobin A1c) with Fasting Insulin, Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) with ApoB (Apolipoprotein B), Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC) with Differential and Uric Acid. Rapamycin raises lipids and can cause cytopenias; sodium-glucose cotransporter inhibitors change renal handling; and a baseline is what makes any of that interpretable.
- Metformin first if anything, and with the cobalamin cost acknowledged. It has the human file Knowler 2025 Lee 2021, it is cheap, and it is a prescription. Its interaction with training adaptation is an open question rather than a settled objection.
- Rapamycin is the most mechanistically supported and the most clinical item here. If it is used at all it belongs with a physician, a schedule chosen deliberately Arriola Apelo 2016 Baghdadi 2024, and Sirolimus (Rapamycin), Whole Blood trough measurement, which is the rare case where the compound has an established therapeutic drug monitoring assay.
- Acarbose and Canagliflozin are the carbohydrate-handling arm and their animal results are sex-dependent Snyder 2023 Wezeman 2022. Acarbose's gastrointestinal effects are the practical limit on it, and canagliflozin carries a genital mycotic infection and euglycemic ketoacidosis profile that belongs in the decision.
- Spermidine, Calcium AKG and Green Tea (EGCG) are the dietary end and the safest. Spermidine has cohort data Kiechl 2018 on top of the animal work Eisenberg 2016; alpha-ketoglutarate's headline is an invertebrate lifespan result Chin 2014.
- Berberine and Dihydroberberine are AMPK activators with a drug-interaction problem. Repeated administration inhibits human cytochrome P450 enzymes Guo 2012, which matters more on this page than elsewhere because the rest of the shelf is prescriptions.
- AICAR, MOTS-c, Klotho (alphaKlothoLR) and 17-alpha-Estradiol are the research tail. 17-alpha-estradiol's lifespan result was in male mice specifically Harrison 2021; AICAR's human work is acute metabolic physiology rather than aging. None of the four has a human dosing schedule anybody can defend.
What gets bought for this that cannot move it
The category that fails is the caloric restriction mimetic bought by somebody who is not in nutrient excess. These molecules signal scarcity. In a person whose nutrient sensing is already spending time in the scarcity state, the signal is redundant, and the mouse data cannot help because laboratory mice are sedentary, ad-libitum fed and metabolically nothing like a trained adult. That is the specific reason the Interventions Testing Program result Harrison 2009 does not transfer as a dose.
Nicotinamide riboside is the clearest documented disappointment on this shelf and it is worth naming. In the same program that produced positive results for rapamycin and for 17-alpha-estradiol, nicotinamide riboside did not affect lifespan in either sex Harrison 2021. The NAD precursors are argued at NAD+ & sirtuin signaling, and the honest starting point there is this null.
And mTOR inhibition has a cost that the longevity framing obscures. mTOR is how muscle responds to loading. Suppressing it in somebody whose priority is retaining muscle into old age is a trade, not a free lunch, and the schedule literature exists largely because of it Arriola Apelo 2016 Baghdadi 2024. A reader running rapamycin and a hypertrophy program at the same time is paying for two things that oppose each other, which is the argument at Androgen & anabolic-receptor signaling.
If the mechanism you want is different, so is the page. Clearing damaged organelles is Autophagy & mitochondrial quality control. Removing senescent cells is Cellular senescence & senolytics. Cross-linking and glycation is Glycation, oxidation & protein damage. And the interventions with human mortality endpoints are collected at The unglamorous evidence — what actually has mortality data, which is the page to read before this one.
How you would know it was working, on a real read-out and a real timescale
The prediction here is that the metabolic markers move and the aging does not become measurable. If HbA1c (Hemoglobin A1c) and Fasting Insulin fall on an AMPK-directed agent, the drug is doing its pharmacology. That is not the same as the claim on the page, and no marker in the estate measures the claim on the page.
- HbA1c (Hemoglobin A1c) with Fasting Insulin at baseline and 12 weeks. Twelve weeks for the red cell reason. These two are the honest read-out of every AMPK and glucose-handling agent here, and they are the read-out the 21-year human trial used a version of Knowler 2025.
- Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) with ApoB (Apolipoprotein B) before and after any rapamycin exposure. Lipid elevation is a documented consequence of mTOR inhibition and it is the commonest reason a schedule gets changed Arriola Apelo 2016.
- Complete Blood Count (CBC) with Differential and Comprehensive Metabolic Panel (CMP) on the same schedule. Cytopenias, mouth ulceration and impaired wound healing are the mTOR-inhibition adverse effects that appear first, and a white cell count is how they are detected before they are felt.
- Sirolimus (Rapamycin), Whole Blood trough levels if rapamycin is being used. This is the only compound on the page with a validated therapeutic drug monitoring assay, which means it is the only one where the question of what exposure is actually being delivered has an answer Baghdadi 2024.
- Vitamin B12 annually on Metformin, and Uric Acid once. Both are cheap, both change management if abnormal, and neither is measured by anybody buying these compounds for longevity.
What will fool you. Everything on this page is started by people who are simultaneously training more and eating better, and those two move every marker listed. A falling HbA1c is a metabolic result and is not evidence about lifespan. Animal lifespan results are sex-specific often enough that assuming yours applies is a coin flip Harrison 2021 Wezeman 2022. Berberine will change the exposure of co-administered drugs while looking like a clean glucose success Guo 2012. And no biological age calculator on the market has been shown to respond to any of these compounds, which is why none of them appears in this read-out.
Sources read for these sections
- Harrison DE. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009 · PMID 19587680
- Harrison DE. 17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex. Aging Cell 2021 · PMID 33788371
- Snyder JM, et al. Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male mice. GeroScience 2023 · PMID 35974129
- Wezeman J, et al. Sex Matters in Aging. The Canagliflozin Story. Aging Pathobiology and Therapeutics 2022 · PMID 36540066
- Arriola Apelo SI, et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell 2016 · PMID 26463117
- Baghdadi M, et al. Intermittent rapamycin feeding recapitulates some effects of continuous treatment while maintaining lifespan extension. Molecular Metabolism 2024 · PMID 38360109
- Chin RM, et al. The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 2014;510(7505):397-401 · PMID 24828042
- Eisenberg T, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine.. Nature Medicine 2016 · PMID 27841876
- Kiechl S, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study.. American Journal of Clinical Nutrition 2018 · PMID 29955838
- Knowler WC. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. Lancet Diabetes and Endocrinology 2025 · PMID 40311647
- Lee CG. Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care 2021 · PMID 34697033
- Guo Y, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology 2012 · PMID 21870106
The other 5 routes to longevity & healthspan
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
You know the goal. Skool has the plan.
This pathway is one arm of The Longevity & healthspan Blueprint. The members' version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.
Open The Longevity & healthspan Blueprint in Skool →$10/mo, cancel anytime.
← Open this pathway in the interactive Vault
Frequently asked questions
The most conserved longevity mechanism across every species tested. Persistent nutrient abundance signals growth; scarcity signals repair and maintenance. Everything in this pathway is a way of telling the cell that food is scarce when it isn't.
13 options are mapped to this pathway in the Vault, including Rapamycin, Metformin, Acarbose, Canagliflozin. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 5 carry clinical validation and 6 are mechanistic predictions.
Fasting insulin and IGF-1 are the two readable outputs of the nutrient-sensing system this whole pathway targets. They also tell you whether an intervention is doing anything, which nothing else here does. The markers worth checking are Fasting Insulin, HbA1c (Hemoglobin A1c), IGF-1 (Insulin-like Growth Factor 1), Uric Acid.
Unproven is not the same as ineffective. Of the 13 options on this pathway, 5 have clinical validation and 6 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.
Where this goes next
Everything above is the free case for Nutrient sensing — mTOR, AMPK & caloric restriction mimetics. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.